Incanthera PLC Company Webinar Presentation
01 Aprile 2021 - 8:00AM
RNS Non-Regulatory
TIDMINC
Incanthera PLC
01 April 2021
1 April 2021
Incanthera plc
("Incanthera" or the "Company")
Company Webinar Presentation
Incanthera plc (AQSE: INC), the specialist oncology company
focused on transforming cancer treatment, is pleased to announce a
Company presentation via a live webinar hosted by London South East
on Tuesday 6 April 2021.
Chairman, Tim McCarthy and Chief Executive Officer, Simon Ward
will give a presentation on the Company's current corporate status
and activities, followed by a Q & A session.
The live webinar will host five companies during the event,
which can be accessed live at 6.00 p.m. on Tuesday 6 April.
In order to register to attend the event, please use the Zoom
link posted below.
https://us02web.zoom.us/webinar/register/5516055554838/WN_anEDYN4dT9iMKM2_EZRdfA
The webinar event will provide the opportunity for investors to
hear an update on the Company's current corporate activities,
including plans following the recent fundraising announced on 23
March 2021, discussion on its portfolio and near to market asset,
Sol, an innovative skin cancer formulation.
A copy of this notification is available via the company's
website at www.incanthera.com
The directors of the Company take responsibility for this
announcement.
For further enquiries:
Incanthera plc
www.incanthera.com
Tim McCarthy, Chairman
tim.mccarthy@incanthera.com
Simon Ward, Chief Executive Officer
simon.ward@incanthera.com +44 (0) 7831 675747
Suzanne Brocks, Head of Communications +44 (0) 7747 625506
suzanne.brocks@incanthera.com +44 (0) 7776 234600
Notes to Editors:
Incanthera is a specialist oncology company focused on
transforming cancer treatment by creating environments in which
cancer cannot survive. It seeks to identify and develop innovative
solutions to current clinical, commercially relevant unmet needs,
utilising new technology from leading academic institutions.
The Company's current lead product and focus is Sol, a
potentially innovative topical product for the treatment of solar
keratosis and the prevention of skin cancers.
The Company originated from the Institute of Cancer Therapeutics
("ICT") at the University of Bradford and has acquired and
developed a portfolio of specific cancer-targeting therapeutics
through a Pipeline Agreement with the ICT and other corporate
acquisitions.
Incanthera's strategy is to develop each candidate in the
portfolio from initial acquisition or discovery to securing its
future through commercially valuable partnerships at the earliest
opportunity in its development pathway.
For more information on the Company please visit:
www.incanthera.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRADKDBQPBKDPNN
(END) Dow Jones Newswires
April 01, 2021 02:00 ET (06:00 GMT)
Grafico Azioni Incanthera (AQSE:INC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Incanthera (AQSE:INC)
Storico
Da Apr 2023 a Apr 2024